Loading clinical trials...
Loading clinical trials...
The purpose of this study is to add further understanding to the doses of hymecromone that effectively and safely lead to the inhibition of hyaluronan synthesis. In this study we will investigate both...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Paul Bollyky
NCT05545306 · Obesity, Normal Physiology, and more
NCT07269301 · Hepatic Impairment, Healthy
NCT07554365 · Healthy Volunteer, Healthy Participants Study
NCT06096532 · Healthy, Aging
NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension
Stanford University
Palo Alto, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions